-
-
Call more information
660-596-2224 -
Interview with Michael Clark, MD Antidepressants are commonly prescribed to manage chronic pain so a meta-analysis was conducted to determine how well this class of medications was tolerated, and the extent of adverse effects occurring in patients with chronic pain. Chronic pain affects 36% of the US population and accounts for 12% of all medication […]
Read MoreAuthors: Nasir Hussain, M.Sc., M.D et al Anesthesiology published on October 12, 2017. Background: Interscalene block provides optimal shoulder surgery analgesia, but concerns over its associated risks have prompted the search for alternatives. Suprascapular block was recently proposed as an interscalene block alternative, but evidence of its comparative analgesic effect is conflicting. This meta-analysis compares the analgesic […]
Read MoreASA Monitor 10 2017, Vol.81, 50-51. Review of unusual patient care experiences is a cornerstone of medical education. Each month, the AQI-AIRS Steering Committee abstracts a patient history submitted to the Anesthesia Incident Reporting System (AIRS) and authors a discussion of the safety and human factors challenges involved. Real-life case histories often include multiple clinical decisions, […]
Read MoreAuthor: Zeev N. Kain, M.D., M.B.A., FAAP ASA Monitor 10 2017, Vol.81, 18-20. Zeev N. Kain, M.D., M.B.A., FAAP, is Chancellor’s Professor of Anesthesiology and Medicine, Director, Stress and Health, University of California, Irvine, Adjutant Professor, Yale University, New Haven. The American medical environment is currently experiencing a dramatic transformation, and much of that relies on […]
Read MoreHow to Get an A for a Nuss Procedure: Management of Arrhythmias, Arrests, Allergies and Analgesia! By Lauren M. Lobaugh, M.D. A Nuss procedure is a surgical correction of a pectus excavatum chest wall deformity. It is not a common procedure, so many anesthesiologists are not familiar with it and its possible complications. A Problem-Based […]
Read MoreAuthors: Maryanne Z. A. Mariyaselvam, M.B.B.S. et al Anesthesiology 10 2017, Vol.127, 658-665 Background: Retained central venous catheter guidewires are never events. Currently, preventative techniques rely on clinicians remembering to remove the guidewire. However, solutions solely relying upon humans to prevent error inevitably fail. A novel locked procedure pack was designed to contain the equipment required for […]
Read MoreAuthors: Jason M. Slagle, Ph.D. et al Anesthesiology published on October 19, 2017. Background: When workload is low, anesthesia providers may perform non–patient care activities of a clinical, educational, or personal nature. Data are limited on the incidence or impact of distractions on actual care. We examined the prevalence of self-initiated nonclinical distractions and their effects on […]
Read MoreAuthors: Vanessa A. Olbrecht, M.D., M.B.A. et al Anesthesiology published on October 19, 2017. Background: General anesthesia during infancy is associated with neurocognitive abnormalities. Potential mechanisms include anesthetic neurotoxicity, surgical disease, and cerebral hypoxia–ischemia. This study aimed to determine the incidence of low cerebral oxygenation and associated factors during general anesthesia in infants. Methods: This multicenter study enrolled […]
Read MoreHaving women lie down during the second stage of labor after an epidural is associated with increased rates of spontaneous vaginal birth without an increase in complications, according to a randomized trial in The BMJ. Roughly 3200 nulliparous U.K. women who received low-dose epidurals were assigned to undergo the second stage of labor (after the cervix […]
Read MoreInjectable extended-release naltrexone (Vivitrol) appears to be as safe and effective as daily oral buprenorphine-naloxone for treating opioid dependence, according to a Norway-based, noninferiority trial in JAMA Psychiatry. Roughly 160 opioid-dependent adults who were discharged from addiction treatment programs were randomized to receive either oral buprenorphine-naloxone daily or extended-release intramuscular naltrexone every 4 weeks for 12 […]
Read More